0.534

9.49% -0.056

Prophase Labs Inc (PRPH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Prophase Labs Inc stock is traded at $0.534, with a volume of 14.25M. It is down -9.49% in the last 24 hours and down -12.32% over the past month. ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Previous Close:

$0.59

Open:

$0.6

24h Volume:

14.25M

Relative Volume:

1.74

Market Cap:

$12.75M

Revenue:

$62.71M

Net Income/Loss:

$-10.48M

P/E Ratio:

-0.8476

EPS:

-0.63

Net Cash Flow:

$-13.77M

1W Performance:

+64.31%

1M Performance:

-12.32%

6M Performance:

-81.13%

1Y Performance:

-89.21%

1-Day Range:

$0.51

$0.6288

1-Week Range:

$0.376

$0.78

52-Week Range:

$0.2179

$7.48

Prophase Labs Inc Stock (PRPH) Company Profile

Name

Prophase Labs Inc

Sector

Healthcare (1169)

Industry

Diagnostics & Research (60)

Phone

(215) 345-0919

Address

711 STEWART AVE, SUITE 200, NEW YORK, PA

Employee

113

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PRPH's Discussions on Twitter

Compare PRPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRPH Prophase Labs Inc	0.534	12.75M	62.71M	-10.48M	-13.77M	-0.63
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-21	Initiated	H.C. Wainwright	Buy
Oct-13-21	Downgrade	Dawson James	Buy → Neutral
Jan-20-21	Initiated	Dawson James	Buy

Prophase Labs Inc Stock (PRPH) Latest News

Feb 21, 2025

ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks

Feb 21, 2025

Feb 20, 2025

ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire

Feb 20, 2025

ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq

Feb 20, 2025

Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan

Feb 20, 2025

Feb 19, 2025

ProPhase Labs hires Stuart Hollenshead as COO - TipRanks

Feb 19, 2025

Feb 18, 2025

ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria

Feb 18, 2025

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire

Feb 18, 2025

ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com

Feb 18, 2025

ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha

Feb 18, 2025

ProPhase Labs appoints Stu Hollenshead as COO - Investing.com

Feb 18, 2025

Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan

Feb 18, 2025

Feb 17, 2025

ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa

Feb 13, 2025

ProPhase Labs appoints new COO amid executive changes - MSN

Feb 13, 2025

Feb 11, 2025

StockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World

Feb 11, 2025

Feb 08, 2025

Following A -1.03% Weekly Decline, Is It Still A Buy For ProPhase Labs Inc (NASDAQ: PRPH)? - Marketing Sentinel

Feb 08, 2025

Feb 04, 2025